Title:
抗ＣＣＲ７抗体薬物コンジュゲート
Document Type and Number:
Japanese Patent JP7312111
Kind Code:
B2
Abstract:
This application discloses anti-CCR7 antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating or preventing cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
Inventors:
Vendor, stephen
Charlton, Tracy
Anna Gulkin
Geierstanger, Bernard Hubert
Glaser, Scott Martin
Kashibatra, Shiraja
Knuth, mark
Rotman, Sabin
Lou, Sara
Glen Sprang
Tetsuro Uno
Charlton, Tracy
Anna Gulkin
Geierstanger, Bernard Hubert
Glaser, Scott Martin
Kashibatra, Shiraja
Knuth, mark
Rotman, Sabin
Lou, Sara
Glen Sprang
Tetsuro Uno
Application Number:
JP2019541414A
Publication Date:
July 20, 2023
Filing Date:
February 01, 2018
Export Citation:
Assignee:
Novartis Age
International Classes:
C12N15/13; A61K31/537; A61K39/395; A61K47/68; A61P35/00; A61P35/02; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08; G01N33/53
Domestic Patent References:
| JP2016519066A | ||||
| JP2008545000A | ||||
| JP2016512832A | ||||
| JP2016531915A |
Foreign References:
| WO2012043533A1 | ||||
| WO2013184200A1 | ||||
| WO2015138615A2 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Tomohiro Maruyama
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Tomohiro Maruyama
Yasuhito Suzuki